Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Association of KMT2C/D loss‐of‐function variants with response to immune checkpoint blockades in colorectal cancer
Ruiqi Liu, Yan-Ling Niu, Chao Liu, et al.
Cancer Science (2023) Vol. 114, Iss. 4, pp. 1229-1239
Open Access | Times Cited: 20

Showing 20 citing articles:

KMT2C and KMT2D aberrations in breast cancer
Emily Tinsley, Philip Bredin, Sinéad Toomey, et al.
Trends in cancer (2024) Vol. 10, Iss. 6, pp. 519-530
Closed Access | Times Cited: 11
Immunotherapy for advanced-stage squamous cell lung cancer: the state of the art and outstanding questions
Yibei Wang, Mohammed Safi, Fred R. Hirsch, et al.
Nature Reviews Clinical Oncology (2025) Vol. 22, Iss. 3, pp. 200-214
Closed Access | Times Cited: 1
Current and future therapies for small cell lung carcinoma
Xiaoqian Zhai, Zhengkun Zhang, Yuxin Chen, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access | Times Cited: 1
Unraveling Emerging Anal Cancer Clinical Biomarkers from Current Immuno-Oncogenomics Advances
Soledad Iseas, Golubicki Mariano, Louis Gros, et al.
Molecular Diagnosis & Therapy (2024) Vol. 28, Iss. 2, pp. 201-214
Open Access | Times Cited: 6
Epigenetics and immunotherapy in colorectal cancer: progress and promise
Tianjiao Dang, Xin Guan, Luying Cui, et al.
Clinical Epigenetics (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 5
Longitudinal circulating tumor DNA monitoring in predicting response to short-course radiotherapy followed by neoadjuvant chemotherapy and camrelizumab in locally advanced rectal cancer: data from a Phase Ⅲ clinical trial (UNION)
Zhenyu Lin, Menglan Zhai, Haihong Wang, et al.
Cancer Letters (2025), pp. 217442-217442
Closed Access
Famitinib plus camrelizumab in patients with advanced colorectal cancer: Data from a multicenter, basket study
Luoyan Ai, Qian Li, Shilong Zhang, et al.
The Innovation (2025) Vol. 6, Iss. 1, pp. 100745-100745
Open Access
Molecular Subtyping and Genomic Profiling Expand Precision Medicine in KRAS Wild‐Type Pancreatic Cancer
Dan Su, Yuli Ruan, Yingfei Shi, et al.
Cancer Science (2025)
Open Access
Landscape of targeted therapies for lung squamous cell carcinoma
Qiuxuan Chen, Xiao-Shuo Zheng, Weiting Cheng, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 3
Comprehensive genomic profiling reveals prognostic signatures and insights into the molecular landscape of colorectal cancer
Jin-Wei Yang, Sihui Zhao, Junyan Su, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 7
Deciphering Brain Metastasis Stem Cell Properties From Colorectal Cancer Highlights Specific Stemness Signature and Shared Molecular Features
Amandine Desette, Pierre‐Olivier Guichet, Sheik Emambux, et al.
Cellular and Molecular Gastroenterology and Hepatology (2023) Vol. 16, Iss. 5, pp. 757-782
Closed Access | Times Cited: 4
Tumour-agnostic plasma assay for circulating tumour DNA predicts outcome in recurrent and/or metastatic squamous cell carcinoma of the head and neck treated with a PD-1 inhibitor
Natasha Honoré, A. van der Elst, Anna Dietz, et al.
European Journal of Cancer (2023) Vol. 195, pp. 113372-113372
Closed Access | Times Cited: 2
Mapping in silico genetic networks of the KMT2D tumour suppressor gene to uncover novel functional associations and cancer cell vulnerabilities
Yuka Takemon, Erin Pleasance, Alessia Gagliardi, et al.
Genome Medicine (2024) Vol. 16, Iss. 1
Open Access
Insights into the mechanisms driven by H3K4 KMTs in pancreatic cancer
Kayla C. LaRue-Nolan, Glancis L. Raja Arul, Ashley N. Sigafoos, et al.
Biochemical Journal (2024) Vol. 481, Iss. 15, pp. 983-997
Closed Access
Case report: Macrophage activation syndrome in a patient with Kabuki syndrome
Jingyuan Zhang, Yuanbo Kang, Zenan Xia, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
The modification role and tumor association with a methyltransferase: KMT2C
Yunjuan Jiao, Yuanhao Lv, Mingjie Liu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
WITHDRAWN: Involvement of KMT2 (MLL) family of methyltransferases in head and neck squamous cell carcinoma: A systematic review
Marcos Santos, Anna Karolina de Carvalho Abreu, Fábio Willian Martins da Silva, et al.
Oral Oncology Reports (2023), pp. 100058-100058
Open Access
Understanding the molecular biology of anal squamous cell carcinoma
Robert J. Samuel, Duncan C. Gilbert
International Journal of Cancer (2023) Vol. 154, Iss. 3, pp. 410-411
Open Access
KMT2 (MLL) family of methyltransferases in head and neck squamous cell carcinoma: A systematic review
Marcos Santos, Anna Karolina de Carvalho Abreu, Fábio Willian Martins da Silva, et al.
Head & Neck (2023) Vol. 46, Iss. 2, pp. 417-434
Open Access
Page 1

Scroll to top